Patent 12082872 was granted and assigned to Neurent Medical on September, 2024 by the United States Patent and Trademark Office.
The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.